ArticleScientific reports2026
Predicting lung cancer stage at diagnosis based on self-reported symptoms and background factors using machine learning models.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting lung cancer stage at diagnosis based on self-reported symptoms and background factors using machine learning models.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to describe and compare background factors and symptoms at diagnosis of patients with non-advanced or advanced stage lung cancer and patients without cancer, and to develop predictive models identifying key variables that contribute to the detection of early and late-stage lung cancer. Univariate logistic regression and three machine learning algorithms were used. Compared to patients without cancer, six background factors and two symptoms differed in non-advanced lung cancer, while 11 background factors and 19 symptoms differed in advanced cases. The machine learning models showed moderate performance in classifying patients with lung cancer from those without cancer. Notably, top predictors extended beyond classic respiratory symptoms. Demographic and lifestyle factors, particularly age, smoking status, and living situation, remained essential alongside symptoms such as pain, appetite loss, weight reduction, and respiratory problems. These findings support integrating clinical, demographic, and patient-reported symptoms to improve lung cancer risk models and refine referral decisions in screening pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.